Skip to content

rTMS in the occipital lobe based on fMRI navigation improves the cognitive function of euthymic bipolar disorder

rTMS in the occipital lobe based on fMRI navigation improves the cognitive function of euthymic bipolar disorder: a prospective, randomized, double blind, controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030675
Enrollment
Unknown
Registered
2020-03-09
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bipolar disorder

Interventions

Group A1:S1 was used as the stimulus site, and 10 true stimuli were followed by 10 false stimuli
Group A2:S1 was used as the stimulus site, and 10 false stimuli were followed by 10 true stimuli
Group B1:S2 was used as the stimulus site, and 10 true stimuli were followed by 10 false stimuli
Group B2:S2 was used as the stimulus site, and 10 false stimuli were followed by 10 true stimuli

Sponsors

The First Affiliated Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 16 to 65 years; 2. Informed is signed by a subject or his lineal relation; 3. Comply with the DSM-IV clinical diagnostic criteria for bipolar depressive disorder; 4. Score of Beck-Rafaelsen Mania Rating Scale = 17 points; 7. The duration of the euthymic period >= 3 months; 8. Right-handed, has completed more than 9 years of compulsory education; 9. Score of the simple wechsler intelligence test > 80 points.

Exclusion criteria

Exclusion criteria: 1. A history of loss of consciousness due to organic brain disease or head trauma; 2. History of any major or unstable cardiovascular, respiratory, nervous system (including epilepsy or significant cerebrovascular disease), kidney, liver, endocrine or immune diseases; 3. Laboratory indicators or ECG abnormalities of clinical significance; 4. Magnetic resonance imaging revealed structural abnormalities in the brain; 5. Have hearing problems; 6. Red, green, blue or yellow color blindness or color weakness; 7. Patients who received ECT or rTMS within six months; 8. Patients with significant mental retardation and history of seizures; 9. History of psychoactive substance abuse and dependence; 10. There are pacemakers, insulin pumps, artificial heart valves and other things that have metal in them; 11. History of using anticholinergic drugs; 12. A pregnant, nursing or planning pregnancy.

Design outcomes

Primary

MeasureTime frame
THINC-it neurocognitive function assessment;Cranial magnetic resonance;

Secondary

MeasureTime frame
17 items of Hamilton depression scale;Bech-Rafaelsdn Mania Rating Scale;

Countries

China

Contacts

Public ContactShaohua Hu

The First Affiliated Hospital, Zhejiang University School of Medicine

dorhushaohua@zju.edu.cn+86 13357169115

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026